EUVIMEDEUVIMED entdecken
Open Access

Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action

Farzaneh Motafeghi iD, Romina Shahsavari, Parham Mortazavi, Aysan Babaei, Pouria SamadiMojaveri, Omid Abed Khojasteh, Mohammad Shokrzadeh

Toxicology Research · 26.08.2023 · 12 (4) · 702-708

DOI: 10.1093/toxres/tfad060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 24.07.2023. Verfasst von Farzaneh Motafeghi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences and Metabolism, Shahid Beheshti University of Medical Sciences,…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mazandaran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin exerts its anticancer effect through two mechanisms, directly affecting the tumor and indirectly reducing systemic insulin levels. The anticancer effects of aspirin occur by inhibiting Cyclooxygenase (COX)-2. COX-2 is absent in many cell types under normal conditions and increases under pathological conditions such as cancer. This study aims to investigate the effect of metformin and aspirin and their combination of them on A549 and PC3 cell lines. Metformin and aspirin were investigated separately and in combination on two cancer cell lines, A549 and PC3. The examined groups include the negative control of untreated cells and the positive control of cisplatin and drugs at concentrations of 15, 10, and 20 μg/ mL to investigate the mechanism of oxidative stress factors (reactive oxygen species, lipid peroxidation, Glutathione (GSH)) and apoptosis (lactate dehydrogenase). The results showed that aspirin, metformin, and their combination could affect cancer cell growth by damaging mitochondria, releasing reactive oxygen species, and activating the oxidative stress pathway. Also, these two drugs show the activation of the apoptotic pathway in cancer cells by increasing the lactate dehydrogenase factor and releasing it from the cells. By disrupting the balance of oxidants and antioxidants in the cell, metformin and aspirin cause an increase in the level of reactive oxygen species and a decrease in the level of glutathione reserves, followed by an increase in the level of lipid peroxidation and a decrease in cell viability. Unlike common chemotherapy drugs, these drugs have no known severe side effects; Therefore, in the not-so-distant future, these drugs can also be used as anticancer drugs. Highlights

Schlagwörter

Stichwörter der Autor:innen

LDHanticancerapoptosisaspirinmetformin

Autor:innen und Institutionen

  • Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences and Metabolism, Shahid Beheshti University of Medical Sciences, Tehran 19839-63113, Iran.
  • Department of Pharmacology and Toxicology, Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari 4847193698, Iran.
  • Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
  • Faculty of medicine, Mazandaran University of Medical Sciences, Sari 4847193698, Iran.
  • Department of Clinical Pharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari 4847193698, Iran.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari 4847193698, Iran.

ORCID-Profile: Farzaneh Motafeghi

Förderung

  • Mazandaran University of Medical Sciences

Zitieren

APA

Motafeghi, F., Shahsavari, R., Mortazavi, P., Babaei, A., SamadiMojaveri, P., Khojasteh, O. A., & Shokrzadeh, M. (2023). Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action. Toxicology Research, 12(4), 702-708. https://doi.org/10.1093/toxres/tfad060

Vancouver

Motafeghi F, Shahsavari R, Mortazavi P, Babaei A, SamadiMojaveri P, Khojasteh OA, et al. Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action. Toxicology Research. 2023;12(4):702-708. doi:10.1093/toxres/tfad060

BibTeX
@article{Motafeghi2023,
  author = {Motafeghi, Farzaneh and Shahsavari, Romina and Mortazavi, Parham and Babaei, Aysan and SamadiMojaveri, Pouria and Khojasteh, Omid Abed and Shokrzadeh, Mohammad},
  title = {Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action},
  journal = {Toxicology Research},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {702--708},
  doi = {10.1093/toxres/tfad060}
}
Kostenlos starten →